Arie Mayer
Director/Board Member bei ORAMED PHARMACEUTICALS INC.
Vermögen: 280 711 $ am 31.03.2024
Profil
Arie Mayer is currently the Chairman & Managing Director at Sigma-Aldrich Israel Ltd.
since 2010 and an Independent Director at Oramed Pharmaceuticals, Inc. since 2019.
He holds a doctorate degree from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2024 | 96 134 ( 0,24% ) | 280 711 $ | 31.03.2024 |
Aktive Positionen von Arie Mayer
| Unternehmen | Position | Beginn |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director/Board Member | 05.12.2019 |
Sigma-Aldrich Israel Ltd.
 Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Chief Executive Officer | 01.01.2010 |
Ausbildung von Arie Mayer
| Technion-Israel Institute of Technology | Doctorate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Health Technology |
